Day One, November 20, 2024 - ET (Eastern Time, GMT-05:00)
- Callie Mertel - Conference Producer, Informa Connect
- Jeff Park - Senior Director, Pricing and Policy Strategy, Nuvation Bio
As pharmaceutical manufacturers continue to adapt their patient support models, the role of single service solutions is growing. Delve into timely industry data, discuss program considerations and learn how to achieve greater agility, scalability and control, while maintaining efficiency amidst this evolving landscape.
- Geri O’Rourke - Manager, Innovation Technologies, Cardinal Health Sonexus Access and Patient Support
- Chas Smith - Director, Cardinal Health™ Sonexus™ Access and Patient Support
This session delves into the latest trends and benchmarks in patient support models, providing a perspective of the benefits and challenges associated with each type. Attendees gain valuable insights into best practices for building, optimizing and seamlessly integrating their patient support models.
- Current trends and best practices in PSP operating models
- Evaluating operating models for benefits and challenges
- Assess strategic decisions for insourcing vs. outsourcing PSP components
- Leveraging specialized providers through enhanced PSP integration
- Josh Konetzni - Vice President, Head of Business Development, VMS BioMarketing
- Patrick Gomez Menzies - Head of Market Access, AIR, US, Chiesi USA, Inc.
- Geoff Fisher - Director, Specialty & Oncology Patient Assistance Programs, GSK
Every day, millions of conversations are happening across all segments of healthcare. Patient conversations hold valuable insights that bridge the gap between patient support services and brand teams. Join for a discussion on the powerful impact conversation data provides at both a micro and macro level by hearing directly from your peers.
- Hear how programs have been able to optimize and deliver positive patient outcomes and results by listening at scale
- Reimagine how leveraging conversations can solve healthcare-specific problems
- Join for an engaging session on how peers are analyzing and leveraging the patient voice in their programs
- Jenna Okoro - Director, Sales, Authenticx
- April Onufrak - Associated Director of Digital Solutions, Lilly Patient Services, Eli Lilly
- Geoff Fisher - Director, Specialty & Oncology Patient Assistance Programs, GSK
- Meghan Jones - Associate Director, Patient Support Services, Rare Blood Disorders, Sanofi
As the patient support landscape continues to evolve so do the regulatory requirements and level of oversight around programs. Hear directly from enforcement agents regarding top trends, focal points and priorities for patient support programs in 2024 and beyond.
- Richard Liner - Senior Assistant General Counsel, Bayer
- Steven Sharobem - Assistant United States Attorney, US Attorney’s Office, District of Massachusetts
- Jonathan Lax - Deputy Chief, Business and Securities Fraud Section, U.S. Attorney’s Office, Eastern District of New York
The future of patient services is already here. Join industry leaders to explore the transformative impact of integrating core hub services directly into provider workflows. Learn how this streamlined approach accelerates key services like benefits verification and prior authorization approvals for patients. Gain insights on the real-world applications that have delivered measurable results for specialty pharmaceutical manufacturers.
- Amanda Wilson - Business Development Leader, CareMetx
- George Moore - Chief Technology & IT Officer, CareMetx
- Michael Sullivan - President, Provider Solutions, CareMetx
- Claudia Stemple - Director, Value & Access Consulting, Syneos Health
As the intricacies surrounding patient access become more complex, so have the compliance challenges faced by manufacturers.
- Discuss what is top of mind on compliance’s radar and why it should also be on yours
- Understand the importance of robust data and an effective vendor partnership in remaining compliant
- Learn the necessity behind compliance, marketing and commercial teams working together to conduct due diligence on your hub and the specific activities that are involved in doing so
- Navigate evolving regulations and enforcement activity with new patient access-related needs to mitigate risk and remain compliant
- Tara Kennedy - Sr. Director Head of Ethics & Compliance North America, Apellis Pharmaceuticals
- Donna White - Vice President, Compliance Officer, Chiesi USA Inc.
- Jonathan Amar - Assistant General Counsel, Sanofi
With field teams on the front lines, it is crucial for organizations to empower their FRMs and sales teams whilst also mitigating compliance risk.
- Uncover best practices in training and monitoring activities, including sensitivity training, whilst remaining compliant
- Discover strategies for field teams to convey program value whilst also being mindful of selling and/or medical language
- Examine how field teams work across the organization, including interactions and rules of engagement for FRMs and the importance of being proactive vs. reactive
- Delve into key areas of concern, including script usage, medical reporting boundaries and compensation nuances
- Melissa Molomby - Associate Director, Ethics and Compliance, Alnylam Pharmaceuticals
- Kristen Butler-Cummings - National Director, Key Account Management & Strategic Advocacy, Pharmacosmos Therapeutics Inc.
- Chrissy Bradshaw - Senior Director, Brand and Compliance Counsel, Rocket Pharmaceuticals
Typically dominated by specialty therapeutics, the patient services industry is noticing an uptake in programs for retail therapies as well. Manufacturers must rethink how to operationalize their programs on a different scale to meet these patients’ needs. During this session, uncover the best path forward to serve retail patients and identify the key differences and challenges in your specialty vs. retail programs.
- Erica Devine - Director, Patient Experience and Support Nephrology/Rare, Otsuka Precision Health
- Meghan Szczech, MBA - Executive Director, Patient Services and Trade, SK Life Science Inc
For the past 6 years Nuvera has captured insights from HCPs and patients related to pharma PSPs through our syndicated PURE Study. As payers continue to increase pressure on pharma, it was important to gain insights into their mindset and anticipated actions that will impact patient access and affordability, particularly as the full implementation of the Inflation Reduction Act comes into focus. Nuvera will share key learnings from these payers and what it means for your patient support programs to ensure your organization is aligned and prepared to address the ongoing and new challenges. We will also share 2024 “Best-in-Class” Pharma Patient Support Programs based on ratings from over 2,000 HCPs.
- Derek Cothran - Principal, Nuvera Life Science Consulting
- Edward Gajewski - Principal, Nuvera Life Science Consulting
Data Privacy regulations are a compliance minefield for patient support programs. During this session, unravel the legal complexities and unpack the evolving regulatory landscape to ensure that your organization is operating compliantly.
- Deep dive into the varying state laws surrounding data privacy and e-prescriptions, and understand their effect on patient consent/signatures/HIPAA
- Benchmark on best practices in AI, cyber and building a compliant website, including the types of information that you are (and are not) allowed to collect and the standard disclaimers that need to be incorporated
- Uncover the patient health information that is necessary for your program, and the controls that should be instated surrounding this data and the data usage
- Corey Dennis - Former Senior Director, Global Counsel, Information Security & Privacy,, Eli Lilly and Company
- Jim Koenig - Partner, Troutman Pepper
Kick-start your afternoon with a personal development summit, hearing real-life experiences of colleagues’ successes, challenges, and individual experiences in creating a more inclusive culture within the patient support sector.
- Understand the correlation between health and financial literacy and patient adherence and engagement
- Benchmark with colleagues on how to revitalize your patient education material to address cultural misconception and/or mistrust and raise awareness surrounding clinical trials
- Brainstorm innovative solutions that manufactures can utilize to better partner with patient advocacy groups
- Emily Gibb - Vice President, Head of Novartis Patient Support Cardiovascular, Renal, and Metabolic, Novartis
- Camille Jimenez - Program Lead, Institute of Translational Equitable Medicine, Pfizer
Rare disease patients face a multitude of challenges, two of which include limited treatment options and a lack of dedicated and holistic support. This session tackles both, empowering industry leaders to create high-touch patient support programs to truly optimize patient outcomes.
- Learn innovative strategies to connect with and educate rare disease patients about available resources, even in the absence of approved therapies
- Explore effective methods for establishing trust and fostering long-term relationships. Discover partnerships, such as with patient advocacy organizations, to collaborate with
- Strategize on building programs that specifically cater to the needs of rare disease populations
- Hear from a caregiver of a rare disease patient to understand the community’s perspective on what is valuable in a patient support program and current gaps
- Liz Turner - Vice President, Global Market Access, Mirum Pharmaceuticals, Inc.
- Kristen Baugher - Senior Product Manager, Patient Marketing, Mirum Pharmaceuticals
When building out your suite of services, you want to ensure that they are here to stay. In order to do so, your program needs to be able to pivot and be flexible with the everchanging marketplace.
- Uncover the best practices in monitoring your program, and specifically your hub, throughout its lifecycle
- Discuss the harms of remaining static, the benefits that both patients and providers derive from an agile program and how smooth communication can help you achieve that
- Jeff Park - Senior Director, Pricing and Policy Strategy, Nuvation Bio
- Danny Sigurdson - CEO, Courier Health
- Suzanne Marinakos - Director, Patient Solutions, Rare Disease, Novo Nordisk